Transvaginal Mesh

The NWHN’s Statement on the FDA Ordering Manufacturers of Surgical Mesh to Stop Selling Devices for Uterine Prolapse

By Cindy Pearson | Apr 16, 2019 | Comments Off on The NWHN’s Statement on the FDA Ordering Manufacturers of Surgical Mesh to Stop Selling Devices for Uterine Prolapse

FOR IMMEDIATE RELEASE Contact: Evita Almassi, [email protected] or (202) 682-6240

The NWHN Testifies for the Use of Better Evidence at the FDA

By Tessa Ruff | Feb 27, 2019 | Comments Off on The NWHN Testifies for the Use of Better Evidence at the FDA

In 2016, the FDA reclassified transvaginal mesh used to repair pelvic organ prolapse (POP) as a Class III device—the highest risk category—in response to over 20,000 adverse event reports during a three-year period alone.

FDA Meeting – Surgical Mesh for Transvaginal Repair of Pelvic Organ Prolapse 

By Cindy Pearson | Feb 12, 2019 | Comments Off on FDA Meeting – Surgical Mesh for Transvaginal Repair of Pelvic Organ Prolapse 

Testimony Delivered at the Meeting of the FDA Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee

What Do I Need to Know About Vaginal Mesh to Treat a Pelvic Organ Prolapse?

By NWHN Staff | Aug 1, 2018 | Comments Off on What Do I Need to Know About Vaginal Mesh to Treat a Pelvic Organ Prolapse?

If you’ve been diagnosed with pelvic organ prolapse (POP), you are far from alone: research indicates up to 50 percent of women over the age of 50 experience POP, which occurs when organs sag or fall into the vaginal canal because of weakened pelvic muscles.